[Myocardial revascularization in chronic coronary artery disease. State of art].


Journal

Kardiologiia
ISSN: 0022-9040
Titre abrégé: Kardiologiia
Pays: Russia (Federation)
ID NLM: 0376351

Informations de publication

Date de publication:
30 Jun 2023
Historique:
received: 09 08 2022
accepted: 31 10 2022
medline: 21 7 2023
pubmed: 20 7 2023
entrez: 20 7 2023
Statut: epublish

Résumé

The review addresses debatable issues of myocardial revascularization in chronic forms of ischemic heart disease, shows major differences between percutaneous coronary intervention and coronary artery bypass grafting in terms of long-term prognosis, and the dependence of the results on the clinical profile of the disease. The review of current publications demonstrates advantages of open surgery in long-term survival and prevention of adverse outcomes in target groups of patients.

Identifiants

pubmed: 37470728
doi: 10.18087/cardio.2023.6.n2263
doi:

Types de publication

English Abstract Journal Article

Langues

rus

Sous-ensembles de citation

IM

Pagination

3-13

Auteurs

N V Popova (NV)

Vishnevsky National Medical Research Center of Surgery, Moscow.

V A Popov (VA)

Vishnevsky National Medical Research Center of Surgery, Moscow; Russian Medical Academy of Postgraduate Education, Moscow.

A S Revishvili (AS)

Vishnevsky National Medical Research Center of Surgery, Moscow; Russian Medical Academy of Postgraduate Education, Moscow.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH